Menopause and Bloating: What the Evidence Actually Shows

---

Menopause and bloating can overlap, and hormone therapy can contribute, but your pattern matters more than blaming hormones. This page is for meal-linked, constipation-linked, or treatment-linked bloating. New frequent bloating—more than 12 times a month with onset under a year—or bloating with early fullness, postmenopausal bleeding, severe pain, vomiting, blood, or weight loss needs prompt in-person assessment.

Here's what nobody told you: the reason your stomach is flat at breakfast and looks six months pregnant by 4pm may have very little to do with how much gas you made. In some people, the diaphragm and abdominal wall are moving in the wrong direction. It has a name, and almost no article about menopause bloating explains it.

Is this page for you?

Best for: your belly swells, tightens, or visibly changes size; you're somewhere in your 40s or 50s; and you want to know what's actually supported versus what's simply repeated.

Not for you if: you have sudden severe pain, repeated vomiting, blood or black stool, faintness, an inability to pass stool or gas, or a rapidly enlarging firm abdomen. Those symptoms need urgent medical care, not an article.

The threshold to remember: bloating or increased abdominal size occurring more than 12 times a month, with the pattern starting less than a year ago, belongs in a prompt in-person appointment—especially when it comes with pelvic or abdominal pain, difficulty eating, or feeling full quickly.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

---

What does the evidence say about menopause and bloating?

The newest longitudinal evidence found greater bloating severity during the early and late menopause-transition stages. But the wider evidence base is still thin: a 2025 scoping review found 122 studies, only 14 longitudinal studies, and just five randomised trials. Menopause and bloating are associated; that does not prove hormones are the sole cause or that HRT treats the symptom.

Both of those things are true at the same time. That's uncomfortable, and it's why you keep getting different answers.

The evidence ladder nobody else puts in one place

Evidence layer	What it found	What it can answer	What it cannot answer
2025 scoping review	122 studies published from 1981–2024; 46 measured bloating or gas	How much research exists and how it was designed	A population prevalence, a single cause, or a proven treatment
2026 Seattle longitudinal study	In 291 women, early and late menopause-transition stages were associated with higher bloating severity in the multivariable model	Whether severity changed with reproductive-aging stage in one long-running cohort	Whether hormone shifts directly caused the symptom, whether the finding applies to every woman, or whether HRT helps
Current FDA drug labels	Several menopause medicines report abdominal or digestive adverse events; one Prometrium combination-regimen table reports bloating in 12% versus 5% on placebo	What happened in each product's own trial	Which product is least likely to bloat you, or whether a rate from one label can be compared with another

That is the honest map: a credible new association, an uneven research field, and product-specific adverse-event data that cannot be turned into a universal answer.

What the 2025 research audit found

The scoping review by Naomi Shaw, Rachel Abbott, and Claire Pettinger searched nine databases and mapped research on gastrointestinal symptoms during natural perimenopause and postmenopause. It found:

What the audit found	The number
Studies included, 1981–2024	122
Studies that measured bloating or gas	46 (37.7%)
Studies where digestive symptoms were the main thing being studied	22 (18%)
Studies that did not state how menopause stage was defined	44 (36%)
Snapshot, or cross-sectional, studies	89 (73%)
Studies that followed women over time	14 (11.5%)
Randomised controlled trials	5 (4.1%)
Studies from South America	1 (0.8%)

Read that fourth row again. More than a third did not state how they decided who counted as perimenopausal or postmenopausal. Some studies used age or broad self-identification rather than consistent reproductive-aging criteria.

You're not getting mixed messages because you're confused. You're getting mixed messages because the underlying research has been measured unevenly.

One more thing matters: the review focused on natural perimenopause and postmenopause and excluded research designed around hormone-therapy adverse effects. It cannot answer whether your prescription is causing your bloating. That needs a different evidence source—the drug label and your own timeline—which we use below.

What changed in May 2026

The strongest new evidence arrived after the scoping review's search window closed.

The Seattle Midlife Women's Health Study published a dedicated bloating analysis online on May 27, 2026. It used diary data from 291 women who could be classified by reproductive-aging stage; 131 also supplied urine samples for reproductive- and stress-related biomarkers. (Kamp et al., 2026)

In the multivariable model:

• early menopause transition was associated with increased bloating severity;
• late menopause transition was associated with increased bloating severity;
• increasing age and testosterone levels were associated with lower severity;
• tension was associated with higher severity.

That is the clearest longitudinal evidence yet that stage and bloating severity can move together. It still does not prove a simple chain of “estrogen fell, therefore your belly swelled.” It also does not test HRT as a treatment.

The confident internet version—“menopause hormones cause bloating, so balancing them fixes it”—still outruns the evidence. The version we can defend is stronger because it is narrower: bloating severity can increase during the transition, but the cause and the right next step depend on your pattern.

---

Is it bloating, or is it distension?

Bloating is a sensation—fullness, pressure, tightness, or trapped gas. Distension is a visible increase in abdominal size. The American Gastroenterological Association treats them as different symptoms because you can have one without the other, and the distinction changes what a clinician looks for.

This sounds like hair-splitting. It isn't.

The women who say “I look six months pregnant” are describing a recognised clinical sign. The AGA's 2023 clinical practice update distinguishes subjective bloating from visible distension and tells clinicians to look for different mechanisms.

Why it matters for you:

• If you feel swollen but your waistband has barely changed, gut sensitivity may be carrying more of the symptom.
• If your abdomen visibly grows after meals or through the day, the diaphragm-and-abdominal-wall mechanism below may be relevant.
• If it is visibly bigger, firm, persistent, and not resetting, that is a different situation and needs an examination.

Do not force yourself into one category. You can feel bloated and visibly distend at the same time. The point is to describe both separately when you ask for help.

---

Why are you flat at breakfast and huge by 4pm?

A recognised mechanism called abdominophrenic dyssynergia can explain dramatic visible distension in some people. Instead of the diaphragm relaxing upward while the abdominal wall maintains tone, the diaphragm descends and the front abdominal wall relaxes outward. The visible change can be large even when intestinal gas has not increased enough to explain it.

Say it out loud once—abdominophrenic dyssynergia: AB-dom-ino-FREN-ic dis-in-ER-gee-a.

• “Abdomino” means the abdomen.
• “Phrenic” refers to the diaphragm, the large breathing muscle beneath the lungs.
• “Dyssynergia” means structures that should coordinate are working against each other.

Here's the part that should change how you think about your body.

Imaging and physiologic studies of functional abdominal distension have shown that gas volume is often not the main explanation. Contents can be redistributed downward and forward while the diaphragm descends and the abdominal wall protrudes. A small meal or ordinary amount of gas can trigger a much larger change in silhouette in a susceptible person.

So the volume isn't the whole story. The muscle reflex can be the story.

Think of your abdomen as a room with a ceiling—the diaphragm—and a front wall—the abdominal muscles. In a coordinated response, the room accommodates what is inside without a dramatic outward push. In abdominophrenic dyssynergia, the ceiling comes down while the front wall gives way. The contents move forward. The outline changes.

Three things follow from this:

1. It is not proof you ate too much. A visible change can be out of proportion to the amount of food or gas.
2. It can appear after meals and build through the day. That matches the pattern many women describe.
3. It is not untreatable. The AGA lists diaphragmatic breathing for this pattern, and biofeedback research has shown that retraining thoracoabdominal movement can reduce visible distension in selected patients.

We are not telling you to self-diagnose it. We're telling you it exists, it is in specialist guidance, and it is a real thing to raise with a clinician—because “I get bloated” gets one conversation, and “my abdomen visibly distends after meals, resets overnight, and I want to discuss whether the diaphragm-abdominal-wall pattern could be involved” gets a more useful one.

That is the single most useful sentence you can take from this section into an appointment.

---

Is it bloating, fluid retention, or menopause belly fat?

Four different problems get called “menopause belly,” and they behave differently. Gas and functional distension often change within a day. Peripheral fluid retention usually shows elsewhere too. Fat redistribution is gradual rather than hourly. Fluid accumulating inside the abdomen is a medical finding, not a home-management problem.

Most articles collapse all four into one word. Here's the split.

What it is	What it often feels or looks like	Does it change within a day?	What else may show up	Where it belongs
Bloating and functional distension	Tight, full, pressurised; clothes fit in the morning and not by evening	Often	Burping, gas, constipation, meal relationship, relief after a bowel movement	Pattern tracking, constipation care, diet review, primary care or gastroenterology
Peripheral fluid retention	Puffy or heavy rather than gassy	Sometimes; often worse later in the day	Hands, ankles, feet, or face swell; rings and shoes tighten	Prescriber or primary-care review; sooner with heart, kidney, or breathing symptoms
Abdominal fat redistribution or weight change	Usually softer and not pressure-like	No meaningful hourly reset	Waist or body-shape trend changes over weeks or months	A separate body-composition conversation—see midlife weight care
Fluid inside the abdominal cavity	Persistent enlargement, heaviness, sometimes firmness	No	Breathlessness, ankle swelling, reduced appetite, or another underlying illness	In-person medical evaluation

The overnight comparison

For three days, notice your abdomen when you wake and again in the evening.

• Large morning-to-evening difference that resets overnight? Bloating or functional distension moves higher on the list.
• Roughly the same all day but gradually different from a few months ago? Body composition or another persistent cause moves higher.
• Persistently enlarged, firm, rapidly changing, or paired with breathlessness or swelling elsewhere? Stop testing and book an examination.

This is about noticing what varies. It is not a weight-loss check. No scale, no measuring tape, no targets.

If what you're describing is a gradual body-shape change rather than daily swelling, that is real and deserves a real answer. It is simply a different question from bloating.

---

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

---

When does bloating need to be checked?

One pattern deserves prompt in-person assessment: bloating or increased abdominal size occurring more than 12 times a month and beginning less than a year ago—especially with pelvic or abdominal pain, difficulty eating, or feeling full quickly. That is a validated ovarian-cancer symptom-index threshold. It is a clinical trigger, not a cancer diagnosis or a population screening test.

We're putting this early on purpose. Not to scare you—to get it out of the way so you can read the rest without that thread pulling at you.

The threshold

Barbara Goff and colleagues developed the symptom index using symptoms associated with ovarian cancer:

• pelvic or abdominal pain;
• increased abdominal size or bloating;
• difficulty eating or feeling full quickly;
• urinary urgency or frequency in the exploratory work.

The index was considered positive when a relevant symptom had been present for less than one year and occurred more than 12 times a month. (Goff et al., 2007)

In the confirmatory group, the published performance figures were:

• 56.7% sensitivity for early-stage disease;
• 79.5% sensitivity for advanced disease;
• 90% specificity in women older than 50;
• 86.7% specificity in women younger than 50.

Now the part that keeps this honest

Ninety percent specificity does not mean a woman who meets the threshold has a 90% chance of cancer. It means that, in that study, about one in ten women over 50 who did not have ovarian cancer still met the symptom-index rule.

Many women who meet the threshold will not have cancer. The symptoms overlap with benign ovarian conditions, digestive disorders, urinary conditions, medication effects, and ordinary functional bloating.

The threshold means one thing: book a prompt in-person evaluation rather than beginning another diet experiment. It does not tell you what the cause is.

Both halves are true. You deserve both.

Get urgent or prompt care for these symptoms

Seek urgent medical care for:

• sudden or severe abdominal pain;
• repeated vomiting or an inability to keep fluids down;
• blood in the stool or black, tarry stool;
• fainting, marked weakness, or signs of severe dehydration;
• inability to pass stool or gas with increasing pain and swelling;
• fever with significant abdominal pain.

Book prompt in-person assessment for:

• any bleeding after menopause;
• unexplained weight loss;
• a persistently enlarged or firm abdomen that does not reset;
• new difficulty eating or feeling full after a few bites;
• the more-than-12-times-a-month, less-than-one-year pattern;
• recently worsening symptoms or an abnormal-feeling mass.

This is not a complete emergency list. When something feels acutely wrong, use local urgent or emergency care.

What is not automatically an emergency

Competitor pages often list red flags so broadly that everything looks alarming. It isn't.

These patterns are commonly handled through a routine appointment when they are stable and no alarm feature is present:

• bloating that reliably comes and goes with meals;
• a pattern that improves overnight;
• symptoms that have been stable for years;
• bloating alongside an established, managed IBS diagnosis;
• constipation-linked bloating without severe pain, vomiting, bleeding, or inability to pass gas.

Frequent or disruptive? Worth a routine appointment. Suddenly severe or progressively changing? Different lane.

What an evaluation can involve

Fear of the unknown stops more women from booking than the symptom itself. So here's what usually happens.

A clinician will ask about timing, frequency, bowel changes, appetite, pain, bleeding, medication changes, family history, and whether your abdomen changes visibly. They will examine your abdomen and may also perform a pelvic examination.

Depending on the history and examination, testing may include:

• blood tests;
• coeliac-disease testing;
• a pelvic ultrasound;
• other abdominal or pelvic imaging;
• a CA-125 blood test when ovarian-cancer assessment is clinically indicated;
• endoscopy or colon evaluation when gastrointestinal alarm features point that way.

CA-125 is imperfect. It can rise for reasons other than cancer and can be normal in someone who has cancer. It is interpreted with the history, examination, imaging, menopausal status, and local referral pathway—not alone.

Routine imaging and endoscopy are not recommended for every case of long-standing uncomplicated bloating. But a red-flag or new persistent pattern is not “every case.” That is why the history and examination come first.

---

Which menopause-bloating pattern is yours?

Bloating patterns sort into a handful of recognisable shapes, and the shape is more useful than a single severity score. Where you start—prescriber, primary care, gastroenterology, dietitian, or urgent care—depends on timing, visible change, bowel pattern, associated symptoms, and what changed just before it began.

This is The HRT Index 8-Pattern Map. It is an editorial decision aid, not a diagnostic tool.

Your pattern	What it can point toward (not a diagnosis)	First safe step	When to escalate	Does HRT matter here?
1. Changes through the day—flatter in the morning, larger by evening, resets overnight	Meal-related fermentation, constipation, gut sensitivity, or abdominophrenic dyssynergia	Track meals, bowel movements, sensation, and visible change for 3–7 days before removing foods	Routine appointment if frequent, painful, disruptive, or worsening	Mainly if timing began with a prescription change
2. Follows one food or habit—large meals, dairy, fizzy drinks, sugar alcohols, eating fast	Carbohydrate intolerance, fermentable foods, meal volume, swallowed air	Test one suspected trigger briefly, then reintroduce it	Dietitian or clinician if many foods seem to trigger it or your diet is narrowing	Usually not the first explanation
3. Constipation-linked—fewer stools, hard stool, straining, incomplete emptying	Constipation, slow transit, medication effect, or pelvic-floor dysfunction	Track stool form and frequency; treat constipation properly rather than automatically adding more fibre	Urgent for blood, constant pain, vomiting, or inability to pass gas	Possibly; medication timing can matter
4. Started after HRT or another medication changed	Adverse effect, regimen issue, route or timing issue, or coincidence	Record the exact product, dose, route, start/change date, and daily pattern	Contact the prescriber; urgent care for severe symptoms	Directly relevant
5. Feels swollen but looks similar	Visceral hypersensitivity or another disorder of gut–brain interaction	Track sensation separately from visible size; note sleep, stress, meals, bowel pattern, and pain	Routine review if frequent or changing how you eat	No clear stage-specific answer
6. Constant morning and night	Body-composition change, fluid, medication effect, organ enlargement, or another persistent cause	Separate a several-week trend from the daily log	In-person review; sooner if rapid, firm, breathless, or swollen elsewhere	Do not assume HRT is either cause or cure
7. Constant and progressively worse	Gastrointestinal, gynaecological, urinary, metabolic, or medication-related cause requiring assessment	Stop experimenting with diets. Book an in-person appointment and bring dates	Promptly; sooner with bleeding, early fullness, vomiting, weight loss, or pain	Online HRT care is not the first stop
8. Sudden and severe—abrupt pain, repeated vomiting, fever, faintness, cannot pass stool or gas	Possible obstruction, infection, bleeding, or another acute condition	Seek urgent medical care	Immediately	Do not wait for a hormone appointment

Two women with identical-looking bellies can have completely different causes. The table tells you where to start, not what you have.

Not sure whether online HRT care is even the right lane?

Find My HRT Path asks about your symptoms, history, medication preference, insurance or cash-pay situation, and state. It gives you a best-fit online-care route plus two alternatives—and flags when online care is not the right starting point. The live tool takes about 90 seconds, requires no email, and keeps health answers on the page rather than sending them to The HRT Index. See which HRT-care route fits your situation →

---

Why hasn't a doctor connected bloating to menopause?

Digestive symptoms remain underrepresented in common menopause questionnaires. MENQOL includes bloating and flatulence in its physical domain, but the 21-item Greene Climacteric Scale and 11-item Menopause Rating Scale do not include a dedicated digestive-symptom item. If a tool never asks, the symptom cannot appear in the dataset that tool creates.

This is the part we most want you to read, because it answers a question you may not have asked out loud: am I being dismissed for a real reason, or am I being dismissed?

The three questionnaires

Menopause questionnaire	Number of items	Does it include a dedicated bloating or digestive item?
MENQOL—Menopause-Specific Quality of Life	29	Yes—bloating and flatulence appear in the physical domain
Greene Climacteric Scale	21	No dedicated digestive item
Menopause Rating Scale	11	No dedicated digestive item

Two of the three cannot directly record your bloating even if you have it every day. For the broader symptom picture those scales are trying to capture, see the perimenopause symptoms checklist.

That does not prove one questionnaire caused a guideline omission. It does reveal a measurement blind spot: the instrument shapes the dataset, the dataset shapes the map, and the map shapes what clinicians are trained to expect.

The study that changed this page in 2026

The Seattle Midlife Women's Health Study had already published digestive analyses on constipation, diarrhoea, and abdominal pain. In May 2026, the same long-running cohort produced its dedicated bloating analysis.

The study found early and late menopause-transition stages associated with higher bloating severity after multiple factors were considered. The paper did not make bloating an official diagnostic sign of menopause. It did something more useful: it replaced “there is no longitudinal bloating analysis” with a real, dated finding that can be examined and challenged.

That is how this page should work too. When the evidence changes, the page changes.

About that “77% of women” statistic

You've probably seen it: 94% of perimenopausal and menopausal women reported digestive symptoms, and 77% reported bloating.

The number came from a 2024 UK online survey presented around The Menopause Society's 2025 Annual Meeting and reported in a 2025 press release and conference materials.

Where the number comes from	Detail
Who led it	Nigel Denby, a UK dietitian, with a menopause-support platform
Design	Online survey
Who answered	564 women aged 44–73 who identified as perimenopausal or menopausal
Findings highlighted	94% reported digestive symptoms; 77% bloating; 54% constipation; 50% stomach pain; 49% reflux
Formal IBS diagnosis	33%
Peer-reviewed journal article?	Not cited in the conference and press materials we verified

The number is real for that surveyed group. It is not a population prevalence estimate. Recruitment through a menopause-support context creates a clear self-selection risk: the respondents may not represent all women in perimenopause or postmenopause.

We're still telling you about it because it is one of the largest recent datasets aimed directly at this question. We are also telling you what it cannot prove, because “77% of all women get menopause bloating” is not what the survey established.

We've seen “over 40%” and “40–60%” repeated elsewhere without a traceable primary source. We are not repeating them.

You weren't imagining it

If you've been told “that's just menopause” and left there, that is not a personal failure. A symptom can be common in real life and still be poorly captured by the forms and study designs used to define a field. Map your broader symptoms and care constraints with Find My HRT Path → It also flags when an in-person starting point is safer than online care.

---

Can HRT cause bloating?

Yes, HRT can contribute to bloating—but the cleanest label figure is for a combination regimen, not progesterone alone. In the current Prometrium label, abdominal bloating was reported by 12% of women taking cyclic 200 mg progesterone with conjugated estrogens versus 5% on placebo. The label does not prove which component caused the difference.

We read the current US prescribing information in DailyMed on August 5, 2026. The label is revised February 2026. For the wider medication picture beyond bloating, see HRT side effects.

What the current Prometrium tables actually show

The first table comes from a three-year, placebo-controlled endometrial study. The adverse-event column covers Prometrium 200 mg for 12 days per cycle plus conjugated estrogens 0.625 mg, not progesterone by itself. (Current Prometrium prescribing information)

Reported adverse event	Combination regimen (n=178)	Placebo (n=174)	Difference in percentage points
Abdominal bloating	12%	5%	+7
Abdominal pain	10%	10%	0
Constipation	3%	2%	+1
Diarrhoea	7%	4%	+3
Nausea or vomiting	8%	7%	+1
Swelling of hands and feet	6%	9%	−3
Breast tenderness	27%	6%	+21

The same label has a second table from a different trial for secondary amenorrhea in 49 estrogen-primed postmenopausal women:

Reported adverse event	Prometrium 400 mg (n=25)	Placebo (n=24)
Abdominal distension or bloating	8%	8%
Abdominal pain or cramping	20%	13%
Dizziness	24%	4%

Three things these tables do—and do not—tell you

1. The 12% versus 5% signal is real, but it belongs to a combination regimen.

The table cannot isolate micronized progesterone from conjugated estrogen. Writing “progesterone caused bloating in 12%” would be cleaner copy and worse evidence.

2. The 400 mg table is not a dose-response comparison.

It used a different indication, population, regimen, sample size, and adverse-event reporting threshold. You cannot put 200 mg and 400 mg side by side and conclude that bloating rises, falls, or stays flat with dose.

That damaging admission matters: the label confirms a possible treatment-related symptom, but it does not give us the simple dose story most articles pretend it does.

3. Peripheral swelling and abdominal bloating are not interchangeable measurements.

The label separately warns that progesterone can cause some fluid retention, while the trial table reports swelling of hands and feet less often in the combination group than placebo. Those facts do not cancel each other, and they do not prove the abdominal bloating was gas rather than fluid. They measured different events.

What other menopause-medicine labels show

Product	Type	Label threshold or comparison	Digestive adverse events named	What you can safely conclude
Prometrium plus conjugated estrogens	Combined hormone regimen	Events reported in at least 2% in one study	Bloating 12% vs 5%; abdominal pain 10% vs 10%; diarrhoea 7% vs 4%	Bloating was more frequently reported in that regimen's trial; the table cannot identify the responsible component
Duavee—conjugated estrogens/bazedoxifene	FDA-approved hormone therapy	Common events at 5% or more across four trials	Nausea, diarrhoea, dyspepsia, and upper abdominal pain	Digestive events occur in hormone-therapy trials, but this label cannot be compared directly with Prometrium's trial
Veozah—fezolinetant	FDA-approved nonhormonal hot-flash medicine	At least 2% and above placebo in the label's safety table	Abdominal pain 4.3% vs 2.1%; diarrhoea 3.9% vs 2.6%	Abdominal adverse events are not unique to estrogen or progesterone

Do not rank these products by this table. Every FDA label warns that adverse-event rates from different clinical trials cannot be directly compared. The thresholds, study lengths, populations, background treatments, and ways events were collected differ. This table shows what each label reports. It does not tell you which medicine will be gentlest on your gut.

What route means—and what it does not

Oral estrogen passes through the liver before reaching the wider circulation. Transdermal estrogen delivered by a patch, gel, or spray largely avoids that first pass. That route distinction matters for several clinical decisions, including blood-clot risk.

But there is no verified label-based ranking that says patches cause less menopause bloating than pills. Route is a legitimate prescriber conversation, not a guaranteed gut fix.

Please do not stop or change prescribed HRT on your own. For a woman with a uterus using systemic estrogen, the prescribed endometrial-protection component—usually a progestogen, or bazedoxifene in the Duavee combination—must not be removed independently. Low-dose vaginal estrogen is a different category and does not automatically require the same systemic progestogen arrangement.

The next move is to take your timeline to the prescriber, not to remove one hormone and hope.

---

What can this page not tell you?

No symptom pattern, hormone blood test, food list, or online quiz can prove menopause caused your bloating. No hormone therapy is FDA-approved specifically to treat bloating. This page can sort the next step, expose what the evidence does and does not support, and help you arrive at an appointment with better information. It cannot diagnose the cause.

That's the honest limit of the hormonal explanation, and we'd rather you hear it from us.

If someone offers a hormone panel that supposedly proves your bloating is “estrogen dominance,” “low progesterone,” or another single imbalance, they are selling certainty the test cannot provide. Menopause staging and HRT decisions are not made from one symptom plus one commercial hormone panel.

The plausible buckets include:

• a medication or HRT change;
• constipation or incomplete evacuation;
• a food intolerance or meal pattern;
• a disorder of gut–brain interaction such as IBS or functional bloating;
• abdominophrenic dyssynergia;
• coeliac disease;
• thyroid, gallbladder, urinary, or gynaecological conditions;
• body-composition change or peripheral fluid retention;
• a condition requiring prompt investigation.

HRT is not a diagnostic test for those causes. Starting, stopping, or switching hormones to “see what happens” can muddy the timeline and leave the actual cause untouched.

So the useful move today is not to guess the hormone. It is to walk into the right appointment with your pattern, timing, product details, and four questions.

Four questions to ask about your prescription

1. What exact estrogen and endometrial-protection medicine am I taking, at what dose, by what route, and on what schedule?
2. Is my regimen continuous or cyclical, and does the bloating track the days I take a cyclical progestogen?
3. Could this product or another medicine be contributing, and would a different route, schedule, or product be clinically reasonable for me?
4. What else needs to be ruled out before we blame the prescription?

Write the answers down before the visit. Clinic time is short, and these questions cover more ground than “I've been really bloated” ever will.

---

What actually helps menopause bloating?

There is no well-proven treatment for “menopause bloating” as a single condition. The useful evidence comes from matching treatment to the pattern: treating constipation, reviewing a medication timeline, testing for coeliac disease when appropriate, using dietitian-led food work, checking pelvic-floor dysfunction, and using brain–gut or biofeedback approaches for selected functional patterns.

Anyone promising one universal fix is ahead of the evidence.

Approach	Best fit	Evidence position	What to know
Treat constipation when it is present	Hard or infrequent stool, straining, incomplete emptying	Supported across constipation and IBS-C care	Do not assume “more fibre” is automatically the answer; rapid fibre increases can worsen gas and distension
Review the exact medication timeline	Symptoms that began after HRT, another prescription, or a dose change	Established that medicines can contribute; resolution after switching is individual	Prescriber conversation, not a self-experiment
Diaphragmatic breathing or targeted biofeedback	Visible meal-related distension with suspected abdominophrenic dyssynergia	Guideline-supported; biofeedback trials support benefit in selected patients	Ask a gastroenterologist or trained physical therapist how to do it correctly
Pelvic-floor assessment	Straining, incomplete emptying, or constipation-linked distension	AGA recommends anorectal physiology testing when a pelvic-floor disorder is suspected	Biofeedback is most useful when the problem has been identified
One-variable food test	A repeatable food-linked pattern	Reasonable first-line information gathering	One suspected trigger, a short test, then reintroduction—do not remove five food groups at once
Coeliac-disease testing	Persistent bloating, diarrhoea, iron deficiency, weight loss, family history, or another suggestive pattern	Guideline-supported	Do not start a gluten-free diet before testing without discussing it; removing gluten can affect test accuracy
Central neuromodulators	Visceral hypersensitivity or a disorder of gut–brain interaction	Included in specialist guidance	Some are medicines also used as antidepressants; in GI care they can be used to change pain and sensation processing
Brain–gut behavioural therapy	IBS or functional symptoms with high symptom burden	Supported in GI guidance	Includes cognitive behavioural therapy and gut-directed hypnotherapy; access varies
Gentle movement	General motility and wellbeing	Sensible, but not a proven menopause-bloating cure	Use it because it helps you, not because someone promised a flat stomach

The advice we're deliberately not giving you

Most pages end with “drink more water, add electrolytes, eat more fibre.” We're not doing that.

Blanket fluid and salt advice can be wrong for someone with heart failure, kidney disease, hypertension, or a prescribed fluid restriction. Rapidly increasing fibre can make distension worse. Supplements can interact with medicines or add more fermentable material to an already sensitive gut.

If you have a heart, kidney, liver, or blood-pressure condition, advice about fluids, salt, laxatives, and supplements belongs with your clinician or pharmacist.

That's not a legal disclaimer. That's the actual answer.

---

Do probiotics, peppermint oil, or “debloat” products help?

The evidence is not clean enough to support a generic “menopause probiotic” or debloat product. The AGA's 2023 update advises against probiotics for abdominal bloating and distension. A 2025 European consensus was more permissive about selected strains, but called the benefit strain-specific rather than universal. Peppermint evidence is mixed and comes mainly from IBS, not menopause-specific trials.

Probiotics

The AGA's Best Practice Advice says probiotics should not be used to treat abdominal bloating and distension.

The 2025 European consensus reaches a narrower position: selected probiotic strains may help some people with functional bloating, but the evidence cannot be generalised across products. A jar labelled “women's gut balance” does not tell you whether it contains a studied strain, at a studied dose, for a studied condition.

So here's the buying decision:

• A generic probiotic marketed for menopause bloating is not an evidence-based default.
• A clinician may still recommend a specific strain for a defined condition.
• Do not keep paying for a product that has not produced a clear, repeatable benefit.

Peppermint oil

A placebo-controlled 2021 IBS trial did not find a significant bloating improvement at six weeks, while wider IBS guidance and the 2025 European consensus remain more open to peppermint oil for selected patients.

That is not a contradiction you need to solve by buying three brands. It means peppermint is not a proven menopause-bloating treatment, and any benefit is likely to depend on the underlying disorder and formulation.

Peppermint can worsen reflux in some people and can interact with individual circumstances. Ask a clinician or pharmacist when those issues apply.

“Debloat” products, detoxes, and gut resets

The AGA update warns that people with bloating may be pulled toward ineffective fad diets and herbal products that can cause malnutrition or toxicity.

You're being marketed to, hard, on this exact symptom. The word “natural” does not tell you whether a product works, whether the dose is safe, whether ingredients interact with medicines, or whether it delays evaluation of a new persistent symptom.

Slow, safe, boring, and evidence-based is the actual shortcut.

---

What foods can trigger bloating during menopause?

Food can trigger bloating through fermentation, carbohydrate malabsorption, meal size, carbonation, sugar alcohols, or eating speed. But malabsorption on a breath test is not the same as symptoms, and referral-clinic rates are not population prevalence. The useful move is a short test of one suspected trigger followed by reintroduction—not a permanent “menopause belly” diet.

Common possibilities include:

• lactose-containing foods in someone with lactose malabsorption;
• fructose or fructans in someone who is sensitive to them;
• sugar alcohols such as sorbitol, mannitol, or xylitol;
• fizzy drinks;
• very large meals;
• rapid eating and swallowed air;
• a high fermentable-carbohydrate load;
• abrupt fibre increases.

Not everyone who poorly absorbs a carbohydrate develops symptoms. Gut sensitivity, dose, meal context, bowel transit, and the rest of the day's intake matter. Two people can eat the same meal and have completely different experiences. That is not weakness. It is physiology.

The HRT Index one-variable food test

1. Pick one suspected trigger with a repeatable pattern.
2. Keep the rest of your routine as stable as practical.
3. Remove or reduce that one trigger for about two weeks.
4. Track whether the bloating and visible distension genuinely change.
5. Reintroduce it. This is the step that turns avoidance into information.
6. If symptoms return in a similar pattern, bring that result to a clinician or dietitian.
7. If nothing changes, put the food back and stop restricting it.

Do not stack five eliminations at once. You will end up with a narrow diet and no usable answer.

What about low-FODMAP?

FODMAPs are fermentable carbohydrates found in many ordinary nutritious foods, including onions, garlic, wheat products, some fruits, some dairy, legumes, and sweeteners.

A low-FODMAP diet has evidence for IBS and appears in bloating guidance. It is not meant to become a permanent universal restriction.

The safe version has three parts:

• a limited restriction phase;
• a structured reintroduction phase;
• personalisation so tolerated foods return.

The AGA says dietary modification should preferably be monitored by a gastroenterology dietitian. Guidance also tells clinicians to consider eating-disorder and restrictive-eating risk before recommending elimination.

So here's our position, stated plainly. We will not give you a calorie target, a “flat belly” plan, or a before-and-after challenge. A page like this reaches women with very different medical histories and relationships with food. For some, a restriction plan from a website is the start of a problem bigger than bloating.

The trained professional belongs in that room. So does the reintroduction plan.

---

How long does menopause bloating last?

There is no reliable “menopause bloating lasts X months” figure. The 2025 review found few longitudinal studies, and the 2026 Seattle study identified stage associations rather than a universal duration. When bloating begins with a new or changed HRT regimen, a common review point is about three months. Progressive symptoms are evaluated rather than waited out.

We know that's not the answer you wanted. Here's the useful version instead.

Fluctuating, stable, and without alarm features? Track the pattern and test only one change at a time.

Started after a medication change? Put a review point in the calendar. NHS guidance commonly recommends an HRT review around three months after starting or changing therapy, while severe or concerning effects should be discussed sooner.

Steadily worsening, constant, or changing appetite? Duration is no longer the useful question. Go back to the red-flag section and book an examination.

Anyone who gives every woman the same exact duration is giving precision the studies have not earned.

---

What should you track before your appointment?

Fourteen days of simple notes can transform the appointment. Record whether your abdomen visibly changes, whether it resets overnight, bowel pattern, meals, cycle timing if relevant, medication timing, associated pain or early fullness, and what changed before the symptom began. Bring the actual dates and a monthly frequency estimate—not a memory assembled in the waiting room.

Most women walk in and say “I've been bloated.” That gets a shrug. Walking in with fourteen days of pattern data gets a conversation.

The 14-Day Menopause Bloating Record

Print this section or copy the table into a note. Do not enter health information into a public form or shared device you do not control.

Day/date	Worst time	Felt bloated?	Visibly larger?	Reset overnight?	Stool: none/hard/normal/loose	Meal or trigger note	HRT/medicine and time	Pain, early fullness, nausea, bleeding, or other symptom	One change tried/result
1
2
3
4
5
6
7
8
9
10
11
12
13
14

At the end, write down:

• Bloating days out of 14: ___
• Days with visible distension: ___
• Days it reset overnight: ___
• Days with constipation or incomplete emptying: ___
• First date this pattern began: ___
• Medication or HRT change immediately before it: ___
• Any early fullness, bleeding, weight loss, or persistent pain: ___

If the two-week sample shows bloating on most days, estimate the monthly frequency rather than treating 14 days as a diagnostic test. The original ovarian symptom index uses more than 12 occurrences in a month plus onset within the past year; this record helps describe the pattern but does not reproduce or diagnose from that index.

Then bring the page. Not your memory. The page.

---

Which appointment should you book?

Where to start depends on the pattern, not how embarrassed or uncomfortable it makes you feel. New frequent bloating, early fullness, postmenopausal bleeding, unexplained weight loss, or a persistent enlarged abdomen needs someone who can examine you. Treatment-linked bloating belongs with the prescriber. Stable food- or bowel-linked symptoms usually begin in primary care or gastroenterology.

If this is you	Who to see	What to bring	Timing
Bloating occurring more than 12 times a month, beginning less than a year ago	Primary care, gynaecology, or another clinician who can examine you and arrange pelvic assessment	Start date, monthly frequency, associated pain or early fullness	Prompt appointment
New early fullness, difficulty eating, unexplained weight loss, persistent firm enlargement, or postmenopausal bleeding	In-person clinician	Symptom dates and any bleeding details	Prompt; urgent if severe or rapidly worsening
Began after HRT or another medicine changed	The prescribing clinician or pharmacist, with primary care when needed	Product, dose, route, schedule, change date, symptom record	Within a few weeks; sooner if severe
Constipation, straining, or incomplete emptying	Primary care; gastroenterology or pelvic-floor service if persistent	Stool and symptom pattern	Routine unless alarm features
Repeatable food-linked, day-fluctuating pattern	Primary care or gastroenterology dietitian	One-variable food test and symptom record	Routine
Sudden severe pain, repeated vomiting, blood, fever, faintness, or inability to pass stool/gas	Urgent or emergency care	Go now	Immediately

---

Where does online menopause care fit—and where does it not?

Online menopause care can be a reasonable starting point when bloating began with an HRT change and the job is to review the product, dose, route, schedule, and alternatives. It is not the right starting point when you need an examination, imaging, or assessment of a new persistent red-flag pattern. No video visit can press on your abdomen.

Best for / not for you

Online care may fit if:

• you are already using HRT and want the regimen reviewed;
• your symptoms are stable rather than acute;
• no red-flag pattern above applies;
• your main question is whether the medication timeline matters;
• you can access in-person care if the clinician decides an examination or imaging is needed.

Online care is not the right first stop if:

• the more-than-12-times-a-month, less-than-one-year pattern applies;
• you have new early fullness, postmenopausal bleeding, unexplained weight loss, or a persistent firm abdomen;
• symptoms are sudden, severe, or rapidly worsening;
• you need an actual physical examination or emergency treatment.

Affiliate disclosure: The HRT Index may earn a commission if you use an affiliate link below. That does not change the verified facts, the disqualifications, or the order of recommendations. See the full affiliate disclosure.

Midi Health—for the prescription-review conversation

Midi is a virtual midlife and menopause clinic available across all 50 states. Its fit on this page is specific: a clinician can review your current HRT product, dose, route, schedule, other medicines, and whether a change is clinically reasonable.

Provider-stated versus verified—checked August 5, 2026:

Decision fact	Provider-stated information	What we verified	What it means for you
Self-pay visit price	$250 initial visit; $150 ongoing visit	Same figures on Midi's pricing page and help centre, updated May 2026	These are visit fees; exact medication, lab, imaging, and outside-service costs are separate unless your plan covers them
Insurance	In-network with many major plans; most PPO plans in many areas	Midi says the specific plan matters and directs users to check state and carrier	Do not treat “takes my insurer” as proof your exact plan is in-network
Typical insured out-of-pocket	Around $50 per visit on average	Midi labels this as an average; exact cost depends on deductible, copay, coinsurance, and plan	This is not a guaranteed price
Medicare	Not Medicare-enrolled; Medicare beneficiaries may use self-pay	Confirmed in Midi's help centre	No Midi claims can be submitted to Medicare for visits, medicines, or related services
Medicaid or Medi-Cal	Cannot treat these patients, even as self-pay	Confirmed in Midi's pricing page and help centre	This is a hard eligibility limitation, not an insurance inconvenience
Payment method	Required to secure visits booked under the current billing process	Current help-centre policy says the card is charged after a completed visit	Read the current billing terms before booking
Medication type	Standard HRT pages state that Midi prescribes FDA-approved preparations in multiple routes	Verified on Midi's HRT and menopause pages	Ask for the exact product name and whether it is FDA-approved before accepting a prescription
State access	Available in all 50 states	Confirmed on Midi's site	Individual services and prescribing categories can still have narrower state availability

Primary verification: Midi pricing and insurance, appointment-cost policy, Medicare/Medicaid policy, and HRT options.

FDA-approved and compounded are not equivalent categories. Midi's standard HRT pages describe FDA-approved options. Midi also markets separate Custom Rx products in parts of its business. Any compounded prescription is not FDA-approved, and FDA does not review compounded drugs for safety, effectiveness, or quality before marketing. Ask the clinician to identify the exact finished product and category. (FDA compounding guidance)

Does this sound like your situation—you're on HRT, the bloating started when something changed, and you want the regimen reviewed without pretending a video visit can replace an abdominal examination?

Check Midi's current coverage and cash price in your state →

Sesame—for pay-per-visit access, not a promised examination

Sesame is a cash-pay marketplace for virtual and, where listed, in-person services. It does not bill insurance. Prices are displayed for the specific provider and service at booking, so the number can vary by location, clinician, and visit type.

The honest use here is access—not a guarantee that every area has an in-person appointment or that a clinician will order a particular test or prescription.

What we verified August 5, 2026:

• virtual care is available nationwide;
• in-person listings vary by location and provider;
• the displayed booking price is the price to check rather than a sitewide menopause-care estimate;
• prescriptions are based on the clinician's judgment and medication cost is generally separate;
• Sesame does not bill health insurance;
• for a full refund, cancel at least three hours before a virtual visit or at least 24 hours before an in-person visit; other services have separate terms;
• Sesame is not an emergency service.

Primary verification: Sesame Terms of Service and telehealth service information.

If your pattern requires an examination, use Sesame only when the actual booking clearly says in person and is available near you. Otherwise, book local primary care, gynaecology, urgent care, or another in-person service directly.

See currently listed pay-per-visit options and prices →

Who we did not feature—and why

We did not turn this symptom page into a provider leaderboard. Bloating is primarily an information, pattern, and triage query—not a “best HRT company” query.

We also did not feature a compounded-hormone provider as the answer to a symptom that may require examination. Compounded products do not carry an FDA-approved finished-drug label equivalent to the labels analysed above, and they must not be presented as safer, more natural, or equivalent to FDA-approved products.

This is The HRT Index Verification Standard in practice: read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule across clinical legitimacy, care quality, medication fit, price transparency, and access.

---

What did The HRT Index actually verify?

We checked the current drug label, the newest menopause-bloating study, the wider research map, the GI guidance, the ovarian symptom-index paper, the live Find My HRT Path page, and current provider pricing and eligibility terms. Claims that could not be traced to current primary or authoritative sources were left out rather than repeated.

What	How we checked it	Verified
2026 Seattle bloating study	Journal abstract, methods, results, publication date, and DOI	August 5, 2026
122-study scoping review	Full open-access article and study-characteristics tables	August 5, 2026
Prometrium adverse-event rates and trial designs	Current DailyMed label, revised February 2026	August 5, 2026
Duavee and Veozah digestive adverse events	Current DailyMed/FDA prescribing information	August 5, 2026
Bloating/distension definitions and management	AGA 2023 Clinical Practice Update; 2025 European consensus	August 5, 2026
Abdominophrenic dyssynergia mechanism	Peer-reviewed APD studies/review and AGA guidance	August 5, 2026
Ovarian symptom-index threshold and performance	Goff et al. 2007 primary paper and PubMed record	August 5, 2026
Menopause questionnaire structure	Original/authoritative scale descriptions and item lists	August 5, 2026
77% survey origin	The Menopause Society press release/conference materials and UK factsheet	August 5, 2026
Find My HRT Path duration, privacy, and deliverable	Live Find My HRT Path page and public tool description	August 5, 2026
Midi pricing, insurance, Medicare/Medicaid, billing, and access	Midi's current pricing page and help centre	August 5, 2026
Sesame payment and cancellation terms	Sesame's current service and terms pages	August 5, 2026
Compounded-drug status	Current FDA compounding guidance	August 5, 2026

What we could not verify, and therefore did not publish as fact:

• a universal “40%” or “40–60%” prevalence figure;
• a reliable number of months that menopause bloating lasts;
• a label-based ranking of pills versus patches for bloating;
• a dose-response claim for progesterone based on the two Prometrium tables;
• a universal benefit for probiotics, peppermint, supplements, or a “menopause bloating diet.”

Found something wrong? Use the site's corrections channel so the claim can be re-checked and the verification date updated.

---

Frequently asked questions

Does menopause cause bloating?

Bloating severity can increase during the menopause transition. A 2026 longitudinal Seattle cohort found early and late transition stages associated with greater severity, while the 2025 wider research audit found major design gaps. The defensible answer is that menopause and bloating can be associated—not that hormones are always the sole cause.

Is bloating a symptom of perimenopause?

It is commonly reported, and the newest longitudinal study found higher severity during early and late menopause-transition stages. But bloating remains non-specific: constipation, food triggers, medication effects, IBS, visible distension mechanisms, and conditions requiring examination can produce the same complaint.

Can HRT cause bloating?

Yes. In the current Prometrium label, abdominal bloating was reported by 12% of women taking cyclic Prometrium with conjugated estrogens versus 5% on placebo. That was a combination regimen, so the label cannot prove progesterone alone caused the difference. Talk to the prescriber rather than stopping HRT independently.

Does progesterone cause bloating?

Micronized progesterone may contribute, and its patient information includes bloating among possible adverse effects. The strongest 12% versus 5% clinical-trial table combined progesterone with conjugated estrogens, so it is not a progesterone-only rate. The separate 400 mg trial cannot be used as a dose-response comparison.

Is it bloating or menopause weight gain?

The clearest clue is timing. Bloating and functional distension often fluctuate and may reset overnight. Fat redistribution or weight change develops over weeks or months and does not disappear by morning. They can occur together, so use a daily pattern record rather than assuming one excludes the other.

Why is my stomach flat in the morning and swollen at night?

Meal-related fermentation, constipation, gut sensitivity, and abdominophrenic dyssynergia can all contribute. In that muscle-coordination pattern, the diaphragm descends while the abdominal wall relaxes outward, producing visible distension that may be out of proportion to the amount of gas.

When can bloating be a warning sign of ovarian cancer?

The Goff symptom index uses increased abdominal size or bloating, pelvic or abdominal pain, or difficulty eating/feeling full when a symptom occurs more than 12 times a month and began less than a year ago. Meeting that pattern warrants prompt in-person assessment. It is not a diagnosis or population screening test.

Does estrogen cause water retention?

Fluid retention appears in hormone-therapy warnings and patient information, but abdominal bloating, peripheral swelling, and true fluid accumulation are not interchangeable. Your prescriber needs the exact product, route, dose, other medicines, and whether swelling also appears in the hands, feet, face, or legs.

How long does menopause bloating last?

There is no reliable universal duration. If it began after starting or changing HRT, about three months is a common review point, but severe, progressive, or red-flag symptoms should be discussed sooner. Constant worsening bloating is investigated rather than waited out.

Should I stop HRT if I am bloated?

Not on your own. If you have a uterus and use systemic estrogen, the prescribed endometrial-protection component must not be removed without a clinician-directed replacement plan. Bring the product, dose, route, schedule, change date, and symptom record to the prescriber.

Do probiotics help menopause bloating?

There is no good menopause-specific evidence for a generic probiotic. The AGA advises against probiotics for bloating and distension, while a 2025 European consensus says selected strains may help some functional-bloating patients. That does not support buying an unspecified “menopause gut” blend.

Can menopause cause IBS?

Menopause can overlap with changes in gut symptoms, stress, sleep, pain sensitivity, and bowel patterns, but that does not establish menopause as a universal cause of IBS. Persistent bowel symptoms deserve assessment using standard IBS and gastrointestinal criteria rather than being written off as hormones.

Should I try a low-FODMAP diet?

Possibly when IBS or fermentable-carbohydrate sensitivity is suspected, but it should be time-limited, followed by structured reintroduction, and preferably guided by a gastroenterology dietitian. It is not a permanent “menopause diet,” and it is not the first move for a new persistent red-flag pattern.

What tests might a clinician order?

Testing depends on the history and examination. Possibilities include blood tests, coeliac screening, pelvic ultrasound, other imaging, CA-125 in an ovarian-cancer assessment pathway, and gastrointestinal testing when bowel alarm features point that way. No single test diagnoses “menopause bloating.”

---

Before you close this page

If you take three things away, make it these.

One: count the frequency. Bloating or increased abdominal size occurring more than 12 times a month and beginning less than a year ago is the pattern that gets a prompt in-person appointment—especially with pain or early fullness.

Two: if your abdomen visibly grows through the day and resets overnight, that is a recognised pattern. It may involve more than gas, and it is not proof you ate too much.

Three: if you're on HRT and this began when something changed, do not stop blindly. Write down the product, dose, route, schedule, and date, then take the four questions to the prescriber.

You were not imagining it. You were not making a fuss. This symptom has fallen through research and questionnaire gaps for years—and the May 2026 longitudinal paper finally gives the connection a firmer evidence base without pretending every case has the same cause.

Still not sure which HRT program is right for you?

Take the free Find My HRT Path quiz. In about 90 seconds, it maps your symptoms, history, medication preference, insurance or cash-pay situation, and state to a best-fit care route—and tells you honestly when online care is not the right starting point. Find My HRT Path →

---

Sources

1. Kamp KJ, Callan NGL, Mitchell ES, Heitkemper MM, Woods NF. Bloating During the Menopause Transition: Observations from the Seattle Midlife Women's Health Study. Journal of Women's Health. First published online May 27, 2026.
2. Shaw N, Abbott R, Pettinger C. The volume and characteristics of research on gastrointestinal symptoms in ‘natural’ peri- and postmenopause: a scoping review. Women's Health. 2025;21. DOI: 10.1177/17455057251387470.
3. Moshiree B, Drossman D, Shaukat A. AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and Distention: Expert Review. Gastroenterology. 2023;165(3):791–800.e3.
4. Melchior C, et al. European Consensus on Functional Bloating and Abdominal Distension—An ESNM/UEG Recommendation. United European Gastroenterology Journal. 2025.
5. Damianos JA, et al. Abdominophrenic Dyssynergia: A Narrative Review. American Journal of Gastroenterology. 2023.
6. Villoria A, Azpiroz F, Burri E, et al. Abdomino-phrenic dyssynergia in patients with abdominal bloating and distension. American Journal of Gastroenterology. 2011;106(5):815–819. DOI: 10.1038/ajg.2010.408.
7. Barba E, et al. Thoracoabdominal Wall Motion–Guided Biofeedback Treatment of Abdominal Distention: A Randomized Placebo-Controlled Trial. Gastroenterology. 2024.
8. Goff BA, Mandel LS, Drescher CW, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007;109(2):221–227.
9. PROMETRIUM—progesterone capsule, current US prescribing information. DailyMed, US National Library of Medicine. Revised February 2026.
10. DUAVEE—conjugated estrogens/bazedoxifene prescribing information. DailyMed.
11. VEOZAH—fezolinetant prescribing information. DailyMed.
12. Hilditch JR, Lewis J, Peter A, et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas. 1996;24(3):161–175.
13. Measurement Scales for Menopause. National Center for Biotechnology Information.
14. The Menopause Society. Digestive Health Issues More Common During Perimenopause and Menopause. Press release, October 2025.
15. Women's Health Concern/British Menopause Society. Digestive health and menopause. July 2025.
16. NHS. About hormone replacement therapy, benefits and risks of HRT, and vaginal oestrogen. Accessed August 2026.
17. The Menopause Society. Hormone Therapy and The 2022 Hormone Therapy Position Statement.
18. FDA. Menopause. Compounded hormone and approved-treatment information.
19. FDA. Understanding the Risks of Compounded Drugs. Updated June 2026.
20. Midi Health. Pricing & Insurance and How much will my appointment cost?. Verified August 5, 2026.
21. Midi Health. Medicare and Medicaid self-pay policy and insurance policy. Verified August 5, 2026.
22. Midi Health. Hormone replacement therapy. Medication-form and FDA-approved-product statements. Verified August 5, 2026.
23. Midi Health. Midi Custom Rx. Compounded-product category verified August 5, 2026.
24. Sesame. Terms of Service and telehealth visit information. Verified August 5, 2026.
25. The HRT Index. Find My HRT Path. Live duration, privacy, and routing description. Verified August 5, 2026.